↓ Skip to main content

COVID-19 in B Cell-Depleted Patients After Rituximab: A Diagnostic and Therapeutic Challenge

Overview of attention for article published in Frontiers in immunology, November 2021
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (96th percentile)
  • High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news
8 news outlets
twitter
26 X users

Citations

dimensions_citation
47 Dimensions

Readers on

mendeley
70 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
COVID-19 in B Cell-Depleted Patients After Rituximab: A Diagnostic and Therapeutic Challenge
Published in
Frontiers in immunology, November 2021
DOI 10.3389/fimmu.2021.763412
Pubmed ID
Authors

Anna Furlan, Gabriella Forner, Ludovica Cipriani, Elisa Vian, Roberto Rigoli, Filippo Gherlinzoni, Piergiorgio Scotton

X Demographics

X Demographics

The data shown below were collected from the profiles of 26 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 70 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 70 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 12 17%
Researcher 6 9%
Other 6 9%
Student > Master 6 9%
Professor > Associate Professor 4 6%
Other 10 14%
Unknown 26 37%
Readers by discipline Count As %
Medicine and Dentistry 23 33%
Biochemistry, Genetics and Molecular Biology 6 9%
Agricultural and Biological Sciences 4 6%
Immunology and Microbiology 3 4%
Nursing and Health Professions 1 1%
Other 5 7%
Unknown 28 40%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 76. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 November 2023.
All research outputs
#588,279
of 26,214,973 outputs
Outputs from Frontiers in immunology
#539
of 32,878 outputs
Outputs of similar age
#14,097
of 448,858 outputs
Outputs of similar age from Frontiers in immunology
#32
of 1,527 outputs
Altmetric has tracked 26,214,973 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 32,878 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.6. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 448,858 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 1,527 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.